Metaanalysis of the association of smoking and PTPN22 R620W genotype on autoantibody status and radiological erosions in rheumatoid arthritis

Journal of Rheumatology

Volumn 40, Issue 7, 2013, Pages 1048-1053

  Taylor, Lyndsey H ^a   Twigg, Sarah ^b   Worthington, Jane ^c   Emery, Paul ^d   Morgan, Ann W ^d   Wilson, Anthony G ^d   Teare, M Dawn ^d  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Human Ptpn22; Metaanalysis; Protein; Rheumatoid Arthritis; Smoking

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22;

ARTICLE; BONE EROSION; DISEASE SEVERITY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; PRIORITY JOURNAL; PROTEIN TYROSINE PHOSPHATASE NON RECEPTOR 22 GENE; RHEUMATOID ARTHRITIS; SMOKING;

HUMAN PTPN22 PROTEIN; METAANALYSIS; RHEUMATOID ARTHRITIS; SMOKING;

ALLELES; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; PEPTIDES, CYCLIC; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22; RISK; SMOKING;

EID: 84879920340     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.120784     Document Type: Article

References (21)

1. Marinou I, Maxwell JR, Wilson AG. Genetic influences modulating the radiological severity of rheumatoid arthritis. Ann Rheum Dis 2010;69:476-82.
2. Knevel R, Gröndal G, Huizinga TWJ, Visser AW, Jónsson H, Víkingsson A, et al. Genetic predisposition of the severity of joint destruction in rheumatoid arthritis: A population-based study. Ann Rheum Dis 2012;71:707-9.
3. Marinou I, Healy J, Mewar D, Moore DJ, Dickson MC, Binks MH, et al. Association of interleukin-6 and interleukin-10 genotypes with radiographic damage in rheumatoid arthritis is dependent on autoantibody status. Arthritis Rheum 2007;56:2549-56.
4. Scherer HU, van der Linden MPM, Kurreeman FAS, Stoeken-Rijsbergen G, le Cessie S, Huizinga TWJ, et al. Association of the 6q23 region with the rate of joint destruction in rheumatoid arthritis. Ann Rheum Dis 2010;69:567-70.
5. van der Linden MPM, Feitsma AL, le Cessie S, Kern M, Olsson LM, Raychaudhuri S, et al. Association of a single-nucleotide polymorphism in CD40 with the rate of joint destruction in rheumatoid arthritis. Arthritis Rheum 2009;60:2242-7.
6. Plant D, Bowes J, Potter C, Hyrich KL, Morgan AW, Wilson AG, et al. Genome-wide association study of genetic predictors of anti-tumor necrosis factor treatment efficacy in rheumatoid arthritis identifies associations with polymorphisms at seven loci. Arthritis Rheum 2011;63:645-53.
7. Baka Z, Buzas E, Nagy G. Rheumatoid arthritis and smoking: Putting the pieces together. Arthritis Res Ther 2009;11:238.
8. Lee DM, Phillips R, Hagan EM, Chibnik LB, Costenbader KH, Schur PH. Quantifying anti-cyclic citrullinated peptide titres: Clinical utility and association with tobacco exposure in patients with rheumatoid arthritis. Ann Rheum Dis 2009;68:201-8.
9. Pedersen M, Jacobsen S, Klarlund M, Pedersen BV, Wiik A, Wohlfahrt J, et al. Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides. Arthritis Res Ther 2006;8:R133.
10. Morgan AW, Thomson W, Martin SG, Carter AM, Erlich HA, Barton A, et al. Reevaluation of the interaction between HLA-DRB1 shared epitope alleles, PTPN22, and smoking in determining susceptibility to autoantibody-positive and autoantibody-negative rheumatoid arthritis in a large UK Caucasian population. Arthritis Rheum 2009;60:2565-76.
11. Salliot C, Dawidowicz K, Lukas C, Guedj M, Paccard C, Benessiano J, et al. PTPN22 R620W genotype-phenotype correlation analysis and gene-environment interaction study in early rheumatoid arthritis: Results from the ESPOIR cohort. Rheumatology 2011;50:1802-8.
12. Ruiz-Esquide V, Gomez-Puerta JA, Canete JD, Graell E, Vazquez I, Ercilla MG, et al. Effects of smoking on disease activity and radiological progression in early rheumatoid arthritis. J Rheumatol 2011;38:2536-9.
13. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
14. Maxwell JR, Potter C, Hyrich KL, Barton A, Worthington J, Isaacs JD, et al. Association of the tumour necrosis factor-308 variant with differential response to anti-TNF agents in the treatment of rheumatoid arthritis. Hum Mol Genet 2008;17:3532-8.
15. Young A, Wilkinson P, Talamo J, Dixey J, Jones R, Hunt A, et al. Socioeconomic deprivation and rheumatoid disease: What lessons for the health service? Ann Rheum Dis 2000;59:794-9.
16. Symmons DP, Silman AJ. The Norfolk Arthritis Register (NOAR). Clin Exp Rheumatol 2003;5 Suppl 31:S94-9.
17. Thomson W, Barton A, Ke X, Eyre S, Hinks A, Bowes J, et al. Rheumatoid arthritis association at 6q23. Nat Genet 2007; 39:1431-3.
18. Morgan AW, Robinson JI, Conaghan PG, Martin SG, Hensor EM, Morgan MD, et al. Evaluation of the rheumatoid arthritis susceptibility loci HLA-DRB1, PTPN22, OLIG3/TNFAIP3, STAT4 and TRAF1/C5 in an inception cohort. Arthritis Res Ther 2010;12:R57.
19. Viechtbauer W. Conducting meta-analyses in R with the Metafor package. J Stat Softw 2010. [Internet. Accessed March 12, 2013.] Available from: Www.jstatsoft.org/v36/i03/paper
20. Stolt P, Bengtsson C, Nordmark B, Lindblad S, Lundberg I, Klareskog L, et al. Quantification of the influence of cigarette smoking on rheumatoid arthritis: Results from a population based case-control study, using incident cases. Ann Rheum Dis 2003;62:835-41.
21. Kallberg H, Padyukov L, Plenge RM, Ronnelid J, Gregersen PK, van der Helm-van Mil AH, et al. Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis. Am J Hum Genet 2007;80:867-75.